Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ovarian Neoplasms

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 94 articles: HTML format

Single Articles

June 2009
1. QIAN F , Villella J, Wallace PK, Mhawech-Fauceglia P, et al
   Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. STRAUSS R , Sova P, Liu Y, Li ZY, et al
   Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. LIU P , Khurana A, Rattan R, He X, et al
   Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
   Cancer Res. 2009;69:4843-50.
   PubMed     Related articles    Abstract available
   
   
   May 2009
4. GOURLEY C , Paige AJ, Taylor KJ, Ward C, et al
   WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin {alpha}3.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. DIFEO A , Huang F, Sangodkar J, Terzo EA, et al
   KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   March 2009
6. ECKSTEIN N , Servan K, Hildebrandt B, Politz A, et al
   Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
7. CAO F , Li Z, Lee A, Liu Z, et al
   Noninvasive De novo Imaging of Human Embryonic Stem Cell-Derived Teratoma Formation.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. SCHILDKRAUT JM , Goode EL, Clyde MA, Iversen ES, et al
   Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   February 2009
9. TWOROGER SS , Gate MA, Lee IM, Buring JE, et al
   Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies.
   Cancer Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
10. SLACK-DAVIS JK , Atkins KA, Harrer C, Hershey ED, et al
    Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. STOLZENBERG-SOLOMON RZ , Hayes RB, Horst RL, Anderson KE, et al
    Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
12. CHOI JH , Sheu JJ, Guan B, Jinawath N, et al
    Functional Analysis of 11q13.5 Amplicon Identifies Rsf-1 (HBXAP) as a Gene Involved in Paclitaxel Resistance in Ovarian Cancer.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
13. CHAUHAN SC , Vannatta K, Ebeling MC, Vinayek N, et al
    Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer.
    Cancer Res. 2009;69:765-74.
    PubMed     Related articles    Abstract available
    
    
    January 2009
14. FACA VM , Hanash SM
    In-Depth Proteomics to Define the Cell Surface and Secretome of Ovarian Cancer Cells and Processes of Protein Shedding.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. JIN C , Yang YA, Anver MR, Morris N, et al
    Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    December 2008
16. YANG N , Kaur S, Volinia S, Greshock J, et al
    MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
    Cancer Res. 2008;68:10307-14.
    PubMed     Related articles    Abstract available
    
    
    
17. MOZZETTI S , Iantomasi R, De Maria I, Prislei S, et al
    Molecular mechanisms of patupilone resistance.
    Cancer Res. 2008;68:10197-204.
    PubMed     Related articles    Abstract available
    
    
    
18. ASHWORTH A
    Drug resistance caused by reversion mutation.
    Cancer Res. 2008;68:10021-3.
    PubMed     Related articles    Abstract available
    
    
    
19. SAWICKI JA
    Fetal microchimerism and cancer.
    Cancer Res. 2008;68:9567-9.
    PubMed     Related articles    Abstract available
    
    
    November 2008
20. BARTHOLOMEUSZ C , Rosen D, Wei C, Kazansky A, et al
    PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival.
    Cancer Res. 2008;68:9302-10.
    PubMed     Related articles    Abstract available
    
    
    
21. RAYHMAN O , Klipper E, Muller L, Davidson B, et al
    Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells.
    Cancer Res. 2008;68:9265-73.
    PubMed     Related articles    Abstract available
    
    
    
22. PARK JT , Shih IeM, Wang TL
    Identification of pbx1, a potential oncogene, as a notch3 target gene in ovarian cancer.
    Cancer Res. 2008;68:8852-60.
    PubMed     Related articles    Abstract available
    
    
    
23. SONG H , Koessler T, Ahmed S, Ramus SJ, et al
    Association Study of Prostate Cancer Susceptibility Variants with Risks of Invasive Ovarian, Breast, and Colorectal Cancer.
    Cancer Res. 2008;68:8837-8842.
    PubMed     Related articles    Abstract available
    
    
    October 2008
24. GUERRA E , Trerotola M, Dell' Arciprete R, Bonasera V, et al
    A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.
    Cancer Res. 2008;68:8113-21.
    PubMed     Related articles    Abstract available
    
    
    September 2008
25. LEE YS , Lim KH, Guo X, Kawaguchi Y, et al
    The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.
    Cancer Res. 2008;68:7561-9.
    PubMed     Related articles    Abstract available
    
    
    
26. HUARTE E , Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, et al
    Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity.
    Cancer Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
27. SPADARO F , Ramoni C, Mezzanzanica D, Miotti S, et al
    Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
    Cancer Res. 2008;68:6541-9.
    PubMed     Related articles    Abstract available
    
    
    
28. PON YL , Zhou HY, Cheung AN, Ngan HY, et al
    p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Cancer Res. 2008;68:6524-32.
    PubMed     Related articles    Abstract available
    
    
    
29. PALMA MD , Domchek SM, Stopfer J, Erlichman J, et al
    The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families.
    Cancer Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    July 2008
30. APONTE M , Jiang W, Lakkis M, Li MJ, et al
    Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
    Cancer Res. 2008;68:5839-48.
    PubMed     Related articles    Abstract available
    
    
    
31. MOSERLE L , Indraccolo S, Ghisi M, Frasson C, et al
    The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.
    Cancer Res. 2008;68:5658-68.
    PubMed     Related articles    Abstract available
    
    
    
32. HWANG JY , Mangala LS, Fok JY, Lin YG, et al
    Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
    Cancer Res. 2008;68:5849-58.
    PubMed     Related articles    Abstract available
    
    
    
33. CHOI JH , Park JT, Davidson B, Morin PJ, et al
    Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.
    Cancer Res. 2008;68:5716-23.
    PubMed     Related articles    Abstract available
    
    
    
34. BONOME T , Levine DA, Shih J, Randonovich M, et al
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    Cancer Res. 2008;68:5478-86.
    PubMed     Related articles    Abstract available
    
    
    
35. KIKUCHI R , Tsuda H, Kozaki K, Kanai Y, et al
    Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Cancer Res. 2008;68:5067-75.
    PubMed     Related articles    Abstract available
    
    
    
36. ENGELS K , Knauer SK, Loibl S, Fetz V, et al
    NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
    Cancer Res. 2008;68:5159-66.
    PubMed     Related articles    Abstract available
    
    
    June 2008
37. ABEDINI MR , Muller EJ, Brun J, Bergeron R, et al
    Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
    Cancer Res. 2008;68:4511-7.
    PubMed     Related articles    Abstract available
    
    
    
38. DIMPLE C , Nair SS, Rajhans R, Pitcheswara PR, et al
    Role of PELP1/MNAR signaling in ovarian tumorigenesis.
    Cancer Res. 2008;68:4902-9.
    PubMed     Related articles    Abstract available
    
    
    
39. COWDEN DAHL KD , Symowicz J, Ning Y, Gutierrez E, et al
    Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
    Cancer Res. 2008;68:4606-13.
    PubMed     Related articles    Abstract available
    
    
    
40. ZHANG S , Balch C, Chan MW, Lai HC, et al
    Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
    Cancer Res. 2008;68:4311-20.
    PubMed     Related articles    Abstract available
    
    
    
41. SHEU JJ , Choi JH, Yildiz I, Tsai FJ, et al
    The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1.
    Cancer Res. 2008;68:4050-7.
    PubMed     Related articles    Abstract available
    
    
    April 2008
42. BASU A , Adkins B, Basu C
    Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway.
    Cancer Res. 2008;68:2795-802.
    PubMed     Related articles    Abstract available
    
    
    
43. SWISHER EM , Sakai W, Karlan BY, Wurz K, et al
    Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.
    Cancer Res. 2008;68:2581-6.
    PubMed     Related articles    Abstract available
    
    
    
44. KELEMEN LE , Sellers TA, Schildkraut JM, Cunningham JM, et al
    Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
    Cancer Res. 2008;68:2498-506.
    PubMed     Related articles    Abstract available
    
    
    
45. SAWADA K , Mitra AK, Radjabi AR, Bhaskar V, et al
    Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
    Cancer Res. 2008;68:2329-39.
    PubMed     Related articles    Abstract available
    
    
    
46. LOTAN T , Hickson J, Souris J, Huo D, et al
    c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Cancer Res. 2008;68:2166-75.
    PubMed     Related articles    Abstract available
    
    
    February 2008
47. JEON BH , Jang C, Han J, Kataru RP, et al
    Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Cancer Res. 2008;68:1100-9.
    PubMed     Related articles    Abstract available
    
    
    
48. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Related articles    Abstract available
    
    
    
49. ZECCHINI S , Bianchi M, Colombo N, Fasani R, et al
    The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
    Cancer Res. 2008;68:1110-8.
    PubMed     Related articles    Abstract available
    
    
    
50. KLINCK R , Bramard A, Inkel L, Dufresne-Martin G, et al
    Multiple alternative splicing markers for ovarian cancer.
    Cancer Res. 2008;68:657-63.
    PubMed     Related articles    Abstract available
    
    
    January 2008
51. YANG H , Kong W, He L, Zhao JJ, et al
    MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Cancer Res. 2008;68:425-33.
    PubMed     Related articles    Abstract available
    
    
    
52. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available
    
    
    December 2007
53. WANG J , Zhou JY, Wu GS
    ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
    Cancer Res. 2007;67:11933-41.
    PubMed     Related articles    Abstract available
    
    
    
54. LI L , Ryser S, Dizin E, Pils D, et al
    Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Cancer Res. 2007;67:11876-85.
    PubMed     Related articles    Abstract available
    
    
    
55. GAITHER A , Porter D, Yao Y, Borawski J, et al
    A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.
    Cancer Res. 2007;67:11493-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
56. YOKOYAMA Y , Sedgewick G, Ramakrishnan S
    Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination.
    Cancer Res. 2007;67:10813-10822.
    PubMed     Related articles    Abstract available
    
    
    
57. HALDER J , Lin YG, Merritt WM, Spannuth WA, et al
    Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma.
    Cancer Res. 2007;67:10976-10983.
    PubMed     Related articles    Abstract available
    
    
    
58. LANDEN CN JR , Lin YG, Armaiz Pena GN, Das PD, et al
    Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer.
    Cancer Res. 2007;67:10389-10396.
    PubMed     Related articles    Abstract available
    
    
    
59. LU L , Katsaros D, Rigault de la Longrais IA, Sochirca O, et al
    Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis.
    Cancer Res. 2007;67:10117-10122.
    PubMed     Related articles    Abstract available
    
    
    October 2007
60. CHANG CL , Tsai YC, He L, Wu TC, et al
    Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
    Cancer Res. 2007;67:10047-57.
    PubMed     Related articles    Abstract available
    
    
    
61. RAVIKUMAR S , Perez-Liz G, Del Vale L, Soprano DR, et al
    Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid.
    Cancer Res. 2007;67:9266-75.
    PubMed     Related articles    Abstract available
    
    
    
62. KIM TJ , Ravoori M, Landen CN, Kamat AA, et al
    Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma.
    Cancer Res. 2007;67:9337-45.
    PubMed     Related articles    Abstract available
    
    
    
63. GRANOT D , Addadi Y, Kalchenko V, Harmelin A, et al
    In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors.
    Cancer Res. 2007;67:9180-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
64. IORIO MV , Visone R, Di Leva G, Donati V, et al
    MicroRNA Signatures in Human Ovarian Cancer.
    Cancer Res. 2007;67:8699-8707.
    PubMed     Related articles    Abstract available
    
    
    
65. KRYCZEK I , Wei S, Zhu G, Myers L, et al
    Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma.
    Cancer Res. 2007;67:8900-5.
    PubMed     Related articles    Abstract available
    
    
    
66. STAVENHAGEN JB , Gorlatov S, Tuaillon N, Rankin CT, et al
    Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Cancer Res. 2007;67:8882-90.
    PubMed     Related articles    Abstract available
    
    
    
67. LI X , Shen L, Zhang J, Su J, et al
    Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
    Cancer Res. 2007;67:8716-24.
    PubMed     Related articles    Abstract available
    
    
    
68. CORNEY DC , Flesken-Nikitin A, Godwin AK, Wang W, et al
    MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Cancer Res. 2007;67:8433-8.
    PubMed     Related articles    Abstract available
    
    
    
69. TSUDA N , Chang DZ, Mine T, Efferson C, et al
    Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
    Cancer Res. 2007;67:8378-87.
    PubMed     Related articles    Abstract available
    
    
    August 2007
70. KIKUCHI R , Tsuda H, Kanai Y, Kasamatsu T, et al
    Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer.
    Cancer Res. 2007;67:7095-7105.
    PubMed     Related articles    Abstract available
    
    
    
71. WEI S , Kryczek I, Edwards RP, Zou L, et al
    Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma.
    Cancer Res. 2007;67:7487-94.
    PubMed     Related articles    Abstract available
    
    
    
72. LI B , Allendorf DJ, Hansen R, Marroquin J, et al
    Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.
    Cancer Res. 2007;67:7421-30.
    PubMed     Related articles    Abstract available
    
    
    
73. JACQUEMONT C , Taniguchi T
    Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Cancer Res. 2007;67:7395-405.
    PubMed     Related articles    Abstract available
    
    
    
74. SATPATHY M , Cao L, Pincheira R, Emerson R, et al
    Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
    Cancer Res. 2007;67:7194-202.
    PubMed     Related articles    Abstract available
    
    
    July 2007
75. ROSANO L , Di Castro V, Spinella F, Tortora G, et al
    Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
    Cancer Res. 2007;67:6351-9.
    PubMed     Related articles    Abstract available
    
    
    
76. VENERE M , Snyder A, Zgheib O, Halazonetis TD, et al
    Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Cancer Res. 2007;67:6100-5.
    PubMed     Related articles    Abstract available
    
    
    June 2007
77. ROBINSON-SMITH TM , Isaacsohn I, Mercer CA, Zhou M, et al
    Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
    Cancer Res. 2007;67:5708-16.
    PubMed     Related articles    Abstract available
    
    
    
78. DAIKOKU T , Tranguch S, Chakrabarty A, Wang D, et al
    Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-{delta} Signaling in Epithelial Ovarian Cancer.
    Cancer Res. 2007;67:5285-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
79. HEMPEL N , How T, Dong M, Murphy SK, et al
    Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. BARBER A , Zhang T, Demars LR, Conejo-Garcia J, et al
    Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer.
    Cancer Res. 2007;67:5003-8.
    PubMed     Related articles    Abstract available
    
    
    
81. CHEN Y , Clark S, Wong T, Chen Y, et al
    Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models.
    Cancer Res. 2007;67:4924-32.
    PubMed     Related articles    Abstract available
    
    
    
82. VAN VLERKEN LE , Duan Z, Seiden MV, Amiji MM, et al
    Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
    Cancer Res. 2007;67:4843-50.
    PubMed     Related articles    Abstract available
    
    
    
83. BAK SP , Walters JJ, Takeya M, Conejo-Garcia JR, et al
    Scavenger receptor-a-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
    Cancer Res. 2007;67:4783-9.
    PubMed     Related articles    Abstract available
    
    
    
84. PETROCCA F , Calin GA, Croce CM
    ARLTS1 Trp149Stop Mutation and the Risk of Ovarian Cancer.
    Cancer Res. 2007;67:4534.
    PubMed     Related articles   
    
    
    
85. MASOJC B , Medrek K, Debniak T, Lubinski J, et al
    ARLTS1 Trp149Stop Mutation and the Risk of Ovarian Cancer.
    Cancer Res. 2007;67:4533.
    PubMed     Related articles   
    
    
    
86. DARCY KM , Tian C, Reed E
    A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.
    Cancer Res. 2007;67:4474-81.
    PubMed     Related articles    Abstract available
    
    
    April 2007
87. SCHUMACHER JJ , Dings RP, Cosin J, Subramanian IV, et al
    Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
    Cancer Res. 2007;67:3683-90.
    PubMed     Related articles    Abstract available
    
    
    
88. BEHBAKHT K , Qamar L, Aldridge CS, Coletta RD, et al
    Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.
    Cancer Res. 2007;67:3036-42.
    PubMed     Related articles    Abstract available
    
    
    March 2007
89. HAMA Y , Urano Y, Koyama Y, Kamiya M, et al
    A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate.
    Cancer Res. 2007;67:2791-9.
    PubMed     Related articles    Abstract available
    
    
    
90. TOLMACHEV V , Orlova A, Pehrson R, Galli J, et al
    Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Cancer Res. 2007;67:2773-82.
    PubMed     Related articles    Abstract available
    
    
    
91. JACOBS S , Thompson ER, Nannya Y, Yamamoto G, et al
    Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Cancer Res. 2007;67:2544-51.
    PubMed     Related articles    Abstract available
    
    
    
92. ORLOVA A , Tolmachev V, Pehrson R, Lindborg M, et al
    Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.
    Cancer Res. 2007;67:2178-86.
    PubMed     Related articles    Abstract available
    
    
    
93. SYMOWICZ J , Adley BP, Gleason KJ, Johnson JJ, et al
    Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
    Cancer Res. 2007;67:2030-9.
    PubMed     Related articles    Abstract available
    
    
    
94. MORENO-BUENO G , Fernandez-Marcos PJ, Collado M, Tendero MJ, et al
    Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Cancer Res. 2007;67:1927-34.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: